2420 Organometallics, Vol. 29, No. 11, 2010
Meeuwissen et al.
pulse sequence without gradient. High-resolution mass spectra
(HRMS) were recorded at the department of mass spectrometry
at the University of Amsterdam using FABþ ionization on a
JEOL JMS SX/SX102A four-sector mass spectrometer with
3-nitrobenzyl alcohol as the matrix. IR spectra were recorded on
a Thermo Nicolet Nexus 670 FT-IR apparatus. High-pressure
IR were carried out in a stainless steel 50 mL autoclave equipped
with INTRAN windows (ZnS), a mechanical stirrer, a tempera-
ture controller, and a pressure indicator.
dissolved in 10 mL of THF was added dropwise to the reaction
mixture, which was stirred for 12 h. The product mixture
was filtered over a basic alumina plug. Solvents were evaporated
in vacuo. The product was redissolved in CH2Cl2 and filtered
over a silica plug. The solvents were evaporated in vacuo to
obtain the product. The ligands HL2, HL3, HL5, and HL6 were
obtained in a yield of 20-30% after filtration over silica.
HL2 ((S)-1,1-dibenzyl-3-(dinaphtho[2,1-d:10,20-f][1,3,2]dioxa-
1
phosphepin-4-yl)urea). White powder. H NMR (CD2Cl2, 500
Synthesis of (2R,5R)-2,5-Diphenylpyrrolidine-1-carboxamide.
(2R,5R)-2,5-Diphenylpyrrolidine (1.12 g, 1 equiv, 5 mmol) was
placed in a round-bottom flask. Then 200 mL of distilled water
was added, and the resulting suspension was vigorously stirred.
A 2.75 mL portion of a 2 M aqueous HCl solution (5.5 mmol, 1.1
equiv) was added dropwise to the reaction mixture. After
stirring for 1 h the reaction mixture turned clear and a solution
of 7.5 mmol of KOCN (0.61 g, 1.5 equiv) in distilled water was
added. The reaction mixture was next stirred for 48 h while the
product precipitated from the reaction mixture. The product
was filtered from the turbid reaction mixture and washed
3ꢀ with water and 3ꢀ with hexanes. Yield: 0.93 g (70%) as a
white powder. 1H NMR (300 MHz, CDCl3): δ 1.74 (d, 2H, CH2,
J = 6.3 Hz), 2.48 (br, 2H, CH2), 4.31 (s, 2H, NH2), 5.04 (br, 1H,
CH), 5.46 (br, 1H, CH), 7.2-7.5 (ArH, 10H). 13C{1H} NMR
(75.5 MHz, CDCl3): δ 31.342, 33.380, 62.157, 125.422, 125.923,
126.910, 128.107, 128.657, 129.336, 142.390, 143.846, 157.288
(NH2CON). HRMS (FABþ): m/z calcd for C17H19N2O
([MH]þ) 267.1497, obsd 267.1501.
General Procedure for Phosphinourea Synthesis (phosphorus
amide). N,N-Disubstituted urea (2 mmol, 1 equiv) was dried via
coevaporation with toluene (3ꢀ) and dissolved in 40 mL of
THF. After that the vigorously stirred reaction mixture was
cooled to 0 °C, and 2.2 mmol (1.1 equiv) of n-BuLi was added
dropwise. After 10 min 2 mmol of Ph2PCl (1 equiv) was added
dropwise to the vigorously stirred reaction mixture. The reac-
tion mixture was allowed to heat to room temperature and
stirred for 1 h. The reaction mixture was filtered over basic
alumina, which washed with 2 ꢀ 10 mL of THF. The solvents
from the collected filtrate were evaporated in vacuo. The product
was redissolved in 20 mL of CH2Cl2 and filtered over a silica
plug. The solvents of the collected filtrate were evaporated
in vacuo to obtain the product.
MHz): δ 4.325 (br d, 2H, CH2), 4.553 (br s, 2H, CH2), 5.687
(d, 1H, NH, 2JH-P = 6.5 Hz), 7.1-7.6 (m, 18H, ArH), 7.8-8.1
(m, 4H, ArH). 31P{1H} NMR (CD2Cl2, 121.5 MHz): δ 144.459.
31P NMR (CD2Cl2, 121.5 MHz): δ 144.459 (d, 2JP-H = 6.0 Hz).
13C{1H} NMR (CD2Cl2, 125.7 MHz): δ 50.300 (CH2), 121.420
(CH), 121.759 (CH), 123.606 (Cquat), 124.257 (Cquat), 124.301
(Cquat), 125.117 (CH), 125.271 (CH), 125.322 (CH), 126.366
(CH), 126.480 (CH), 126.608 (CH), 126.715 (CH), 127.330
(CH), 127.689 (CH), 128.246 (CH), 128.478 (CH), 128.518
(CH), 128.820 (CH), 129.056 (CH), 130.076 (CH), 130.718
(CH), 131.319 (Cquat), 131.762 (Cquat), 132.668 (Cquat), 132.762
(Cquat), 146.845 (Cquat), 146.875 (Cquat), 148.500 (Cquat), 157.185
2
(d, NHCON, JC-P = 15 Hz). HRMS (FABþ): m/z calcd
for C35H28O3N2P ([MH]þ) 555.1838, obsd 555.1832. Solution
IR (10 mM, CDCl3): ν = 3408 cm-1 (NHfree band), 1646 cm-1
(COurea band).
HL3 ((R)-3-(dinaphtho[2,1-d:10,20-f][1,3,2]dioxaphosphepin-4-
yl)-1,1-dimethylurea). White powder. 1H NMR (CDCl3, 500
MHz): δ 2.86 (s, 6H, CH3), 5.56 (d, 1H, NH, 2JH-P = 6.0 Hz),
7.2-7.6 (m, 8H, ArH), 7.9-8.1 (m, 4H, ArH). 31P{1H} NMR
(CDCl3, 202.3 MHz): δ 144.298. 13C{1H} NMR (CDCl3, 125.7
MHz): δ 36.424 (CH3), 121.542 (CH), 122.121 (CH), 123.933
(Cquat), 123.950 (Cquat), 124.323 (Cquat), 124.365 (Cquat), 125.151
(CH), 125.266 (CH), 126.441 (CH), 126.483 (CH), 126.908 (CH),
126.976 (CH), 128.317 (CH), 128.490 (CH), 128.515 (CH),
128.127 (CH), 129.852 (CH), 130.750 (CH), 131.302 (Cquat),
131.739 (Cquat), 132.820 (Cquat), 147.022 (Cquat), 147.054
(Cquat), 148.605 (Cquat), 156.906 (d, NHCON, 2JC-P = 15 Hz).
HRMS (FABþ): m/z calcd for C23H20N2O3P ([MH]þ) 403.1212,
obsd 403.1216.
HL5 ((R)-1,1-dibenzyl-3-(2,6-dimethyldinaphtho[2,1-d:10,20-f]-
[1,3,2]dioxaphosphepin-4-yl)urea). White powder. 1H NMR
(CD2Cl2, 500 MHz): δ 2.48 (s, 3H, CH3), 2.58 (s, 3H, CH3), 4.3
(br, 2H, CH2), 4.5 (br, 2H, CH2), 5.72 (d, 1H, NH, 2JH-P = 6.9
Hz), 7.1-7.9 (m, 20H, ArH). 31P{1H} NMR (CD2Cl2, 202.3
MHz): δ 143.787. 13C NMR (CD2Cl2, 75.5 MHz): δ 17.178,
17.422, 50.336, 123.418, 123.450, 124.297, 124.371, 124.961,
125.143, 125.249, 125.379, 126.480, 126.508, 127.407 (br),
127.593, 127.693, 128.765, 129.687, 130.075, 130.169, 130.190,
130.347, 131.110, 131.354, 131.373, 131.479, 11.500, 131.554,
136.708 (br), 146.218, 146.271, 147.520, 147.543, 157.206
HL1 (1,1-dibenzyl-3-(diphenylphosphino)urea). Yield: 47%,
white powder. 1H NMR (CDCl3, 500 MHz): δ 4.58 (s, 4H,
2
CH2), 5.04 (d, 1H, NH, JH-P = 6.9 Hz), 7.0-7.6 (m, 20H,
ArH). 31P{1H} NMR (CDCl3, 202.3 MHz): δ 25.518. 31P NMR
(CD2Cl2, 202.3 MHz): δ 25.518 (d, 2JP-H = 6.7 Hz). 13C{1H}
NMR (CDCl3, 125.7 MHz): δ 51.465 (CH2), 127.498 (CH),
127.739 (CH), 128.528 (CH), 128.579 (CH), 128.958 (CH),
129.207 (CH), 130.996 (CH), 131.171 (CH), 137.732 (Cquat),
139.713 (Cquat), 139.837 (Cquat), 158.264 (d, NHCON, 2JC-P
=
2
(d, NHCON, JC-P = 16 Hz). HRMS (FABþ): m/z calcd for
15 Hz). HRMS (FABþ): m/z calcd for C27H26N2OP ([MH]þ)
425.1783, obsd 425.1790. Solution IR (10 mM, CDCl3): ν =
3412 cm-1 (NH band), 1650 cm-1 (CO band).
C37H32O3N2P ([MH]þ) 583.2151, obsd 583.2154.
HL6 ((2S,5S)-N-((11bR)-dinaphtho[2,1-d:10,20-f][1,3,2]dioxa-
phosphepin-4-yl)-2,5-diphenylpyrrolidine-1-carboxamide). White
powder. 1H NMR (CD2Cl2, 500 MHz): δ 1.77 (s, 2H, CH2), 2.48
(br, 2H, CH3), 4.78 (s, 1H, CH), 5.25 (d, 1H, NH, 2JH-P = 5.5
Hz), 5.56 (s, 1H, CH), 7.0-7.6 (m, 18H, ArH), 7.8-8.2 (m, 4H,
ArH). 31P{1H} NMR (CD2Cl2, 202.3 MHz): δ 145.497. 13C{1H}
NMR (CD2Cl2, 75.5 MHz): δ 31.015 (CH2), 33.410 (CH2),
62.056 (CH), 121.446 (CH), 122.121 (CH), 123.872 (Cquat),
123.974 (Cquat), 124.016 (Cquat), 124.994 (CH), 125.043 (CH),
125.357 (CH), 126.229 (CH), 126.767 (CH), 126.904 (CH),
127.734 (CH), 128.314 (CH), 128.515 (CH), 128.871 (CH),
129.417 (CH), 130.410 (CH), 131.213 (Cquat), 131.478 (Cquat),
132.634 (Cquat), 132.737 (Cquat), 141.253 (Cquat), 143.421 (Cquat),
146.912 (Cquat), 146.942 (Cquat), 148.428 (Cquat), 154.932
HL4 ((2R,5R)-N-(diphenylphosphino)-2,5-diphenylpyrrolidine-
1-carboxamide). Yield: 75%, white powder. 1H NMR (300 MHz,
CD2Cl2): δ 1.81 (d, 2H, CH2, J = 5.7 Hz), 2.56 (s, 2H, CH2), 4.82
(d, 1H, NH, 2JH-P = 7.5 Hz), 5.10 (br, 1H, CH), 5.56 (br, 1H,
CH), 6.7-7.5 (ArH, 20H). 31P{1H} NMR (125.7 MHz, CD2Cl2):
δ 23.53. 13C{1H} NMR (75.5 MHz, CD2Cl2): δ 31.289, 33.400,
62.417, 125.381, 126.036, 126.733, 128.249, 128.331, 128.493,
128.584, 128.620, 129.302, 130.126, 130.406, 131.203, 131.499,
139.716, 139.785, 139.902, 140.007, 142.891, 144.204, 155.569 (d,
2
NHCON, JC-P = 18 Hz). HRMS (FABþ): m/z calcd for
C29H28N2OP ([MH]þ) 451.1939, obsd 451.1935.
General Procedure for Phosphinourea Synthesis (phospho-
ramidite). N,N-Disubstituted urea (2 mmol, 1 equiv) was dried
via coevaporation with toluene (3ꢀ), dissolved in 40 mL of
THF, and cooled to 0 °C, and an excess of dry triethylamine was
added. After 10 min 2 mmol of phosphorchloridite (1 equiv)
2
(d, NHCON, JC-P = 15 Hz). HRMS (FABþ): m/z calcd for
C37H30O3N2P ([MH]þ) 581.1994, obsd 581.1999.
General Procedure for Complex Synthesis. To a Schlenk filled
with 1 mmol (2 equiv) of phosphinourea ligand and 0.5 mmol